Hey @michaelmina_lab it looks like the FDA updated their antigen test approval guidelines on Oct 6th: https://www.fda.gov/media/137907/download. There’s a new clause in the asymptomatic evaluation section avoid avoiding participants with recent +PCR. Should help fix the post-infectiousness bias?